Related Experiment Videos
A new immunomodulator, FR-900490.
T Shibata1, O Nakayama, M Okuhara
1Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Ibaraki, Japan.
The Journal of Antibiotics
|September 1, 1988
Summary
FR-900490, a novel immunoactive substance from Discosia sp., restores bone marrow colony-forming units. This compound shows potential in counteracting immunosuppression and chemotherapy-induced bone marrow suppression.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Immunosuppressive factors can impair bone marrow function.
- Chemotherapeutic agents like mitomycin C (MMC) also suppress bone marrow activity.
- There is a need for substances that can restore bone marrow health.
Purpose of the Study:
- To investigate the immunoactive properties of FR-900490.
- To determine if FR-900490 can restore suppressed bone marrow colony-forming units (cfu-c).
- To evaluate the efficacy of FR-900490 in vivo against mitomycin C-induced bone marrow suppression.
Main Methods:
- FR-900490 was isolated from the fungus Discosia sp. F-11809.
- In vitro studies assessed FR-900490's effect on bone marrow cfu-c suppressed by an immunosuppressive factor from tumor-bearing mice.
- In vivo studies evaluated FR-900490's effect on bone marrow cfu-c in mitomycin C-treated mice.
Main Results:
- FR-900490 restored normal levels of bone marrow cfu-c in vitro when suppressed by an immunosuppressive factor.
- Subsequent administration of FR-900490 significantly increased bone marrow cfu-c in mice treated with mitomycin C.
- FR-900490 demonstrated a restorative effect on bone marrow cells depressed by MMC.
Conclusions:
- FR-900490 is a novel immunoactive substance with bone marrow restorative properties.
- FR-900490 shows potential as a therapeutic agent to counteract immunosuppression and chemotherapy side effects.
- Further research into FR-900490's mechanism of action and therapeutic applications is warranted.